Recombinant Drosophila grimshawi Serine/threonine-protein kinase PLK4 (SAK), partial

Shipped with Ice Packs
In Stock

Description

Functional Insights from Orthologs

PLK4/SAK is essential for centriole duplication, and its dysregulation leads to mitotic defects or centrosome amplification. Key findings from Drosophila models include:

Critical Roles in Centriole Biogenesis

  • Canonical Duplication: PLK4 phosphorylates STIL at S428 to stabilize CPAP binding, linking cartwheel assembly to microtubules .

  • De Novo Assembly: Overexpression in D. melanogaster egg explants induces centriole formation independent of cell cycle or pre-existing centrioles .

  • Autoregulation: PLK4 autophosphorylates its DRE to recruit Slimb/β-TrCP, triggering self-ubiquitination and degradation. Mutation of S293 (DRE residue) stabilizes PLK4 and causes centriole overduplication .

Substrate Phosphorylation

SubstratePhosphorylation SiteFunctional OutcomeReference
Ana2 (STAN)S305, S306, S308Enables Sas6 recruitment for cartwheel formation
STILS428Stabilizes CPAP interaction
Asl/Spd2UndeterminedReleases centrioles from apical cortex

Molecular Interactions and Regulation

Recombinant PLK4 partial proteins are used to study interaction networks:

Interaction Partners

PartnerRole in PLK4 Regulation/FunctionMechanismReference
Slimb/β-TrCPE3 ubiquitin ligase mediating PLK4 degradationBinds phosphorylated DRE (S293/T297)
Sas6Cartwheel protein recruited via phosphorylated Ana2Essential for procentriole assembly
PP5 phosphataseDephosphorylates PLK4, counteracting autophosphorylationModulates kinase activity and stability

Experimental Use of Recombinant PLK4

  • Kinase Assays: Truncated PLK4 (kinase domain + DRE) is used to study autophosphorylation kinetics and substrate specificity .

  • Structural Studies: Crystallography of the polo-box domain (PB3) reveals binding interfaces with STIL-CC, critical for centriole duplication .

  • Dominant-Negative Constructs: Kinase-dead PLK4 (K43M) sequesters Asl/Spd2, blocking centriole duplication in Drosophila S2 cells .

Key Data from D. melanogaster Studies

ConstructPhenotype in S2 CellsCentriole Count (PLP Spots)Reference
WT-Plk4 (high expression)Centriole amplification>2
KD-Plk4 (kinase-dead)Centriole loss (<2) via Asl sequestration<2
Plk4-SBM (S293A/T297A)Stabilized, overduplication>2

Implications and Gaps

While D. grimshawi-specific studies are absent, insights from D. melanogaster and human PLK4 highlight conserved mechanisms. Recombinant partial PLK4 is pivotal for:

  • Cancer Research: PLK4 overexpression drives centrosome amplification, a hallmark of genomic instability .

  • Ciliopathies: PLK4 depletion in Drosophila spermatocytes abolishes axoneme formation, modeling ciliary defects .

Note: The absence of direct studies on D. grimshawi PLK4 underscores the need for species-specific biochemical characterization.

Product Specs

Form
Lyophilized powder. We preferentially ship the in-stock format. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specific delivery times. All proteins ship with blue ice packs by default. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
SAK; GH16744; Serine/threonine-protein kinase PLK4; EC 2.7.11.21; Polo-like kinase 4; PLK-4; Serine/threonine-protein kinase SAK
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Drosophila grimshawi (Fruit fly) (Idiomyia grimshawi)
Target Names
SAK
Uniprot No.

Target Background

Function
Serine/threonine-protein kinase PLK4 plays a key role in centriole duplication. It triggers procentriole formation on the mother centriole, recruiting proteins like sas-6. Overexpression induces centrosome amplification during S phase, which can lead to tumorigenesis, highlighting the importance of centrosome regulation in cancer.
Database Links
Protein Families
Protein kinase superfamily, Ser/Thr protein kinase family, CDC5/Polo subfamily
Subcellular Location
Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole.

Q&A

What is the primary function of PLK4/SAK in Drosophila cells?

PLK4 (Polo-like kinase 4), also known as SAK, functions as the master regulator of centriole duplication in Drosophila and other organisms. Its primary role is controlling centriole biogenesis through phosphorylation of key substrates involved in procentriole formation. More recent research demonstrates PLK4 has additional functions beyond canonical duplication, including orchestrating centriole symmetry breaking and influencing mitotic spindle orientation (MSO) in asymmetrically dividing neural stem cells. This occurs through its regulation of centrosome positioning via Spd2 phosphorylation, which induces centriole release from the apical cortex. This functional relationship links centrosome biogenesis machinery with the mitotic spindle orientation apparatus, revealing PLK4's broader role in cellular organization beyond simple duplication control .

How is PLK4/SAK structurally characterized and what are its key domains?

Drosophila PLK4/SAK is a serine/threonine protein kinase (EC 2.7.11.21) characterized by a conserved N-terminal kinase domain and C-terminal polo-box domains that mediate protein-protein interactions and centriolar targeting. The protein contains critical regulatory regions that control its stability and activity through autophosphorylation. The recombinant partial protein typically preserves the kinase domain and key regulatory sequences necessary for experimental applications . Full characterization typically requires a combination of structural biology techniques (X-ray crystallography, cryo-EM) and biochemical approaches to map functional domains and interaction surfaces.

What experimental systems are most appropriate for studying PLK4 function in Drosophila?

Drosophila neural stem cells (neuroblasts or NBs) provide an excellent model system for studying PLK4 function, particularly for investigating asymmetric division and spindle orientation. These cells exhibit robust patterns of centriole asymmetry that control mitotic spindle orientation and ensure consistent positioning of daughter cells . Studies have successfully employed both in vivo approaches using transgenic flies and ex vivo brain culture systems that enable live imaging of dividing neuroblasts. For biochemical studies, recombinant PLK4 proteins expressed in yeast systems with >85% purity (as verified by SDS-PAGE) provide suitable material for in vitro kinase assays and interaction studies . When designing experiments, researchers should consider whether full-length or partial PLK4 constructs are appropriate based on the specific research question.

How can PLK4 activity be experimentally manipulated to study its function in centriole duplication?

PLK4 activity can be manipulated through several complementary approaches. First, expression of kinase-dead versions (such as GFP-tagged kinase-dead Plk4, often referred to as Plk4KD) allows competitive inhibition of endogenous PLK4 function without affecting localization . Hypomorphic mutants (Plk4mut) provide an alternative genetic approach for studying partial loss of function. For gain-of-function studies, overriding PLK4's auto-destruction mechanisms through mutation of key phosphorylation sites results in protein stabilization and increased activity, typically leading to supernumerary centrosomes . Time-lapse microscopy of fluorescently tagged PLK4 and centriolar markers in living cells provides dynamic information about its recruitment and activity. For biochemical validation, in vitro kinase assays using recombinant PLK4 and putative substrates (like Spd2) can confirm direct phosphorylation relationships and identify specific target residues.

What methodological approaches can distinguish between PLK4's roles in centriole duplication versus its non-canonical functions?

Distinguishing between canonical and non-canonical PLK4 functions requires careful experimental design. Separation-of-function mutations that affect specific interaction partners or phosphorylation sites can isolate distinct functional pathways. For instance, studies have shown that PLK4's role in centriole movement and asymmetry can be separated from its duplication function through specific manipulations of its ability to phosphorylate Spd2 .

A comprehensive approach might include:

  • Super-resolution microscopy (3D SIM) to characterize structural changes in centrosomal components upon PLK4 manipulation

  • Combination of PLK4 manipulation with mutations in downstream effectors (Spd2, Fzr) to establish epistatic relationships

  • Phospho-specific antibodies or mass spectrometry to identify and track specific phosphorylation events

  • Time-course experiments to separate temporally distinct functions during the cell cycle

  • Site-directed mutagenesis of specific phosphorylation sites to create phosphomimetic or phospho-deficient variants that isolate specific signaling events

These approaches have revealed that PLK4 orchestrates distinct processes including Spd2 phosphorylation-dependent centriole release from the apical cortex, which influences mitotic spindle orientation independently of its role in duplication .

What are the optimal protocols for analyzing PLK4-mediated phosphorylation events?

For analyzing PLK4-mediated phosphorylation events, researchers should implement multi-faceted approaches:

  • In vitro kinase assays: Use recombinant PLK4 at 0.1-1.0 mg/mL (reconstituted as per manufacturer recommendations) with putative substrates and [γ-32P]ATP or non-radioactive ATP . Reaction products can be analyzed by autoradiography or phospho-specific antibodies.

  • Mass spectrometry analysis: For unbiased identification of phosphorylation sites, LC-MS/MS analysis of substrates after in vitro kinase reactions or immunoprecipitation from cells with manipulated PLK4 activity.

  • Phospho-specific antibodies: Generation of antibodies against known PLK4 phosphorylation sites in substrates like Spd2 or Ana2/STIL for immunofluorescence or western blot analysis.

  • Phospho-mimetic and phospho-deficient mutations: Creating S→E/D (phospho-mimetic) or S→A (phospho-deficient) mutations at identified target sites to assess the functional consequences in vivo.

  • Temporal analysis: Given PLK4's dynamic activity during the cell cycle, synchronization methods combined with time-course experiments provide insight into the timing of specific phosphorylation events.

Notably, research has shown that PLK4 phosphorylates Ana2 (STIL in mammals) at multiple sites with distinct functional outcomes – phosphorylation within the STAN motif regulates interaction with SAS6 for cartwheel assembly, while phosphorylation at S428 in the ANST motif promotes binding to CPAP, linking cartwheel to microtubules of the centriole wall .

How does PLK4 contribute to centriole asymmetry in Drosophila neural stem cells?

PLK4 plays a crucial role in establishing centriole asymmetry in Drosophila neural stem cells through a sophisticated regulatory mechanism. Upon centriole disengagement at mitotic exit, the mother centriole specifically inherits PLK4, which triggers centriole movement toward the basal side of the neural stem cell by disrupting microtubule-organizing center (MTOC) activity . Mechanistically, active centriole-bound PLK4 targets Spd2 (a PCM component), triggering its displacement and promoting the loss of additional PCM proteins from the basal centriole. This asymmetric loss of PCM in the basal centriole is sufficient to trigger movement toward the basal side of the neuroblast.

Additionally, PLK4's phosphorylation of Spd2 results in the loss of Fzr (the APC/C activator Fizzy-related), disabling a mechanism that contributes to maintaining centrosomes at the apical cortex . This PLK4-mediated regulation ensures proper centrosome positioning and mitotic spindle orientation, which is essential for asymmetric cell division of neural stem cells. Experimental evidence for this comes from studies showing that neural stem cells expressing kinase-dead PLK4 (Plk4KD) exhibit defects in centriole asymmetry and spindle positioning, with centrioles remaining anchored at the apical cortex rather than undergoing normal asymmetric positioning .

What is the relationship between PLK4 and its key substrates in centriole formation?

PLK4 interacts with multiple substrates to orchestrate centriole formation in a highly coordinated process:

  • Ana2/STIL interaction: PLK4 phosphorylates Ana2 (the Drosophila homolog of STIL) in two distinct regions with different functional outcomes:

    • Phosphorylation of residues in the STAN motif enables Ana2 to bind SAS6, initiating cartwheel assembly

    • Phosphorylation of S428 in the conserved ANST motif promotes Ana2 binding to CPAP, which links the cartwheel to microtubules of the centriole wall

  • Recruitment dynamics: Ana2 is recruited to the site of procentriole formation ahead of Sas6 in a PLK4-dependent process. Interestingly, PLK4 is initially recruited to multiple sites around the ring of zone II at the centriole periphery, while Ana2 is recruited to a single site in telophase before PLK4 becomes restricted to this same site . This sequential recruitment is critical for proper centriole assembly.

  • Spd2 regulation: PLK4 phosphorylates Spd2, a major PCM component, triggering changes in PCM organization that influence both centriole positioning and microtubule nucleation capacity .

These interactions create a complex regulatory network that ensures the precise spatial and temporal control of centriole biogenesis. Disruption of these phosphorylation events through mutation of target sites or alteration of PLK4 activity leads to abnormalities in centriole number, structure, and positioning.

How do PLK4 levels influence centrosome number and cell division fidelity?

PLK4 levels must be precisely regulated to maintain proper centrosome number and cell division fidelity. This regulation involves a delicate balance:

  • Auto-regulation: PLK4 undergoes auto-phosphorylation that targets it for proteasomal degradation, creating a self-limiting mechanism that prevents excess activity. When this auto-destruction is overridden experimentally, PLK4 remains localized to multiple sites in the outer ring of the centriole and, if catalytically active, recruits Ana2 to these sites . This can lead to supernumerary centrioles.

  • Drosophila model systems: Studies in Drosophila have revealed that both insufficient and excessive PLK4 activity disrupt proper centrosome formation and spindle orientation:

    • Hypomorphic Plk4 mutants show defects in centriole duplication, with only a single centriole detected in approximately 38.9% of neuroblasts

    • Expression of kinase-dead PLK4 (Plk4KD) results in unduplicated centrioles remaining anchored at the apical cortex, disrupting normal asymmetric positioning

    • Overexpression of active PLK4 can lead to centrosome amplification, which compromises spindle bipolarity and chromosomal stability

  • Developmental consequences: Mutations in centrosome genes, including PLK4, reduce mitotic spindle orientation fidelity, leading to tissue dysplasia and causing several diseases such as microcephaly, dwarfism, and cancer . This demonstrates the critical importance of proper PLK4 regulation for normal development and tissue homeostasis.

The precise regulation of PLK4 levels and activity is therefore essential for maintaining genomic stability through proper centrosome duplication and positioning.

What are the optimal storage and handling conditions for recombinant PLK4 protein?

Based on manufacturer recommendations for similar recombinant proteins, optimal storage and handling of recombinant Drosophila PLK4/SAK protein involves:

  • Long-term storage: Store at -20°C, or at -80°C for extended storage stability. The lyophilized form typically maintains activity for approximately 12 months at these temperatures, while the liquid form has a shorter shelf life of about 6 months .

  • Reconstitution protocol:

    • Briefly centrifuge the vial prior to opening to bring the contents to the bottom

    • Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL

    • Add glycerol to a final concentration of 5-50% (with 50% being standard) for long-term storage

    • Aliquot to avoid repeated freeze-thaw cycles

  • Working aliquots: For active experiments, working aliquots can be stored at 4°C for up to one week, but repeated freezing and thawing is not recommended as it may compromise activity .

  • Quality control: Verify protein purity using SDS-PAGE (typical commercial preparations have >85% purity) and assess activity through functional kinase assays with known substrates when setting up new experimental systems .

These handling procedures help maintain the structural integrity and enzymatic activity of the recombinant protein, ensuring reliable and reproducible experimental results.

What controls and validations are necessary for experiments using recombinant PLK4?

Rigorous experimental design for studies using recombinant PLK4 should include several controls and validations:

  • Activity validation:

    • Kinase activity assays using known substrates (e.g., Ana2/STIL or Spd2) to confirm the recombinant protein is functionally active

    • Comparison of phosphorylation patterns between wild-type and kinase-dead versions

    • Dose-response relationships to establish appropriate working concentrations

  • Specificity controls:

    • Inclusion of kinase inhibitors as negative controls

    • Competition assays with unlabeled ATP

    • Parallel assays with other PLK family members to confirm specificity

    • Use of phospho-deficient substrate mutants (S/T→A) to validate phosphorylation sites

  • System-specific validations:

    • For cellular studies, comparison of phenotypes between recombinant protein introduction and genetic manipulations (PLK4 mutants or RNAi)

    • Rescue experiments in PLK4-deficient backgrounds

    • Localization studies to confirm proper targeting to centrioles/centrosomes

  • Technical replications:

    • Independent protein preparations to account for batch-to-batch variation

    • Multiple experimental replicates with appropriate statistical analysis

    • Both in vitro biochemical and in vivo functional validation when possible

These controls ensure that experimental observations are specifically attributable to PLK4 activity rather than technical artifacts or non-specific effects.

How can researchers optimize immunodetection of PLK4 and its phosphorylated substrates?

Optimizing immunodetection of PLK4 and its phosphorylated substrates presents several challenges due to the typically low endogenous expression levels and transient nature of many phosphorylation events. Best practices include:

  • For PLK4 detection:

    • Use of highly specific antibodies validated for the specific Drosophila species being studied

    • Implementation of signal amplification methods for detecting low-abundance endogenous protein

    • Alternative approaches such as epitope tagging (GFP, FLAG) for visualization when antibodies are limiting

    • Note that endogenous PLK4 protein levels are extremely low, making detection challenging even with optimized protocols

  • For phospho-substrate detection:

    • Generation of phospho-specific antibodies against known PLK4 target sites

    • Phosphatase inhibitor treatment during sample preparation to preserve phosphorylation states

    • Phosphatase treatment controls to confirm phospho-specificity

    • Super-resolution microscopy techniques (3D SIM) for detailed localization of centrosomal components

  • Fixation and preservation methods:

    • Optimal fixation protocols that preserve both protein localization and phospho-epitopes

    • Pre-extraction steps to remove cytoplasmic pools and enhance centriolar signal

    • Cold-treatment to preserve dynamic microtubules when studying centrosome function

  • Validation approaches:

    • Correlation of antibody signals with known PLK4 mutant phenotypes

    • Signal co-localization with established centriole/centrosome markers (Asl, γ-tubulin)

    • Comparison of signals between wild-type, kinase-dead, and substrate phospho-mutants

Research has shown that three-dimensional structural illumination microscopy (3D SIM) can be particularly effective for characterizing structural changes in centriolar proteins like Spd2 following PLK4 manipulation .

How does PLK4 function differ across Drosophila species?

While the search results don't provide specific comparisons between PLK4/SAK across different Drosophila species (such as D. persimilis, D. grimshawi, and others), evolutionary conservation patterns suggest:

  • Core functional conservation: The fundamental role of PLK4 in centriole duplication is likely highly conserved across Drosophila species due to its essential cellular function. The kinase domain and key regulatory regions show strong sequence conservation across species.

  • Species-specific variations: Different Drosophila species may exhibit subtle variations in PLK4 regulatory mechanisms, expression patterns, or substrate interactions that could be adapted to specific developmental contexts or cell types unique to each species.

  • Experimental considerations: When working with recombinant proteins from different Drosophila species, researchers should be aware that while core functions are likely conserved, species-specific differences might influence experimental outcomes in subtle ways. Cross-species complementation experiments can provide valuable insights into functional conservation and divergence.

Comparative studies across Drosophila species could reveal evolutionary adaptations in centrosome biology and regulation that contribute to species-specific developmental patterns. Currently, most detailed functional studies have been conducted in D. melanogaster, with more limited information available for other species.

How conserved is the PLK4-mediated centriole duplication pathway between Drosophila and mammals?

The PLK4-mediated centriole duplication pathway shows remarkable conservation between Drosophila and mammals, though with some notable differences:

  • Core components conservation:

    • PLK4 is the master regulator of centriole duplication in both systems

    • Key substrates are conserved but may have different names: Ana2 in Drosophila corresponds to STIL in mammals

    • The STAN motif phosphorylation mechanism for SAS6 recruitment is conserved between flies and mammals

    • The ANST (ANa2-STil) motif is conserved and serves similar functions in both systems

  • Mechanistic similarities:

    • In both systems, PLK4 phosphorylates STIL/Ana2 to promote binding to SAS6 and CPAP

    • The phospho-dependent binding interaction between Ana2/STIL and CPAP is conserved and facilitates stable incorporation of both proteins into the centriole

    • The sequential recruitment of centriole components follows similar patterns

  • Notable differences:

    • Some regulatory mechanisms and feedback loops may differ between flies and mammals

    • Mammals have additional layers of centrosome regulation related to their longer cell cycles and diverse cell types

    • The consequences of PLK4 dysfunction may manifest differently in mammalian systems compared to Drosophila

The high degree of conservation makes Drosophila an excellent model system for studying fundamental aspects of centriole biology relevant to human health and disease, particularly regarding pathologies associated with centrosome dysfunction such as microcephaly, cancer, and ciliopathies.

What insights from Drosophila PLK4 studies have been translated to understanding human centrosomal diseases?

Research on Drosophila PLK4 has contributed significant insights to understanding human centrosomal diseases:

  • Developmental disorders:

    • Studies in Drosophila have shown that mutations in centrosome genes, including PLK4, reduce mitotic spindle orientation fidelity, leading to tissue dysplasia associated with several diseases such as microcephaly, dwarfism, and cancer

    • The mechanisms by which PLK4 dysfunction disrupts neural stem cell division in flies provides a model for understanding how similar defects might contribute to neurodevelopmental disorders in humans

  • Cancer implications:

    • Drosophila studies demonstrating how PLK4 dysregulation leads to centrosome amplification provide mechanistic insights into similar phenomena observed in many human cancers

    • The relationship between improper spindle orientation and tissue dysplasia revealed in fly models helps explain how centrosome abnormalities might contribute to cancer progression

  • Therapeutic implications:

    • Understanding the precise molecular mechanisms of PLK4 regulation and function, including substrate specificity and activity control, informs potential therapeutic approaches targeting centrosome abnormalities

    • Drosophila models allow for rapid genetic manipulation and phenotypic analysis, facilitating the identification of genetic interactions that might be relevant for personalized medicine approaches

The translation from Drosophila findings to human disease contexts is facilitated by the high degree of conservation in centrosome biology between these systems. Insights from fly models continue to inform our understanding of the fundamental cell biological processes that, when disrupted, contribute to human disease.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.